First Trust Morningstar Dividend Leaders Index Fund (FDL) is a publicly traded the market company. As of May 21, 2026, FDL trades at $50.32 with a market cap of $0 and a P/E ratio of 0.00. FDL moved -0.53% today. Year to date, FDL is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces FDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
First Trust Morningstar Dividend Leaders ETF Exposes 5.5% to Merck’s AI Drug Discovery Pact: First Trust Morningstar Dividend Leaders ETF allocates 5.48% of its portfolio to Merck, which launched a strategic AI drug discovery collaboration with Mayo Clinic targeting multiple sclerosis and inflammatory diseases. Merck shares trade 6.1% above their 20-day moving average and near 52-week highs, boosting ETF momentum, pressuring its value profile.
| Metric | Value |
|---|---|
| Price | $50.32 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 597.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
FDL analyst coverage data. Average price target: $0.00.